ANNOUNCEMENT

Save $300 on MedCity CONVERGE Healthcare Innovation Summit July 9-10 in Philadelphia. Earlybird rate ends May 20.

Topic: leukemia

Chimeric antigen receptor therapy may be like penicillin for leukemia

Chimeric antigen receptor therapy may be like penicillin for leukemia

May 19, 2013 4:40 am by | 0 Comments

It is vanishingly rare for an experimental treatment to wipe out advanced, recurrent cancer, then keep the disease from coming back.Yet therapies driven by CARs have been doing exactly that ... Read more
Experimental Gilead drug stalls leukemia for 17 months in early trial

Experimental Gilead drug stalls leukemia for 17 months in early trial

May 15, 2013 6:12 pm by | 0 Comments

(Reuters) - An experimental drug from Gilead Sciences Inc shrank tumors in half of leukemia patients whose cancer had returned, according to an early-stage trial that represents a new foray ... Read more
Cancer drug firm Oncotide develops compounds that may restore cells’ tumor-suppressing abilities

Cancer drug firm Oncotide develops compounds that may restore cells’ tumor-suppressing abilities

March 5, 2013 4:33 pm by | 0 Comments

Cancer cells are sneaky and, unfortunately, smart enough to develop a host of ways to escape the body’s defense mechanisms.A startup called Oncotide Pharmaceuticals is hoping to outsmart some cancer ... Read more
Genetically engineered T cell treatment puts leukemia in remission for 4 people

Genetically engineered T cell treatment puts leukemia in remission for 4 people

December 10, 2012 7:19 am by | 0 Comments

A 7-year-old named Emily Whitehead has erased any remaining doubts about the power of a University of Pennsylvania gene therapy to eradicate certain blood cancers.The therapy is personalized using each ... Read more
Study: Ariad drug put 56% of chronic leukemia patients in remission

Study: Ariad drug put 56% of chronic leukemia patients in remission

December 9, 2012 8:07 am by | 0 Comments

Dec 9 (Reuters) - An experimental leukemia drug from Ariad Pharmaceuticals Inc eliminated the cancer from the bone marrow of nearly half of patients with a ch... ... Read more
The Lancet criticizes Sanofi for cost of Lemtrada, withdrawal of Campath

The Lancet criticizes Sanofi for cost of Lemtrada, withdrawal of Campath

October 31, 2012 8:03 pm by | 0 Comments

PARIS (Reuters) - Medical journal The Lancet warned that Sanofi's experimental multiple sclerosis drug Lemtrada may be too costly for patients and health insurers once it gets approved by regulators.The ... Read more
FDA grants priority review of Ariad leukemia drug

FDA grants priority review of Ariad leukemia drug

October 24, 2012 7:35 am by | 0 Comments

(Reuters) - The Food and Drug Administration has agreed to a priority, or six-month, review of Ariad Pharmaceuticals Inc's experimental leukemia drug ponatinib, the company said on Wednesday.The deadline for ... Read more
Sunesis stock soars as review committee backs cancer trial for myeloid leukemia

Sunesis stock soars as review committee backs cancer trial for myeloid leukemia

September 11, 2012 11:24 am by | 0 Comments

(Reuters) - Shares of Sunesis Pharmaceuticals Inc soared to their highest in two years after the company said a recommendation from an independent committee on the trial of its blood ... Read more
Lundbeck says cancer drug Treanda approved in Canada

Lundbeck says cancer drug Treanda approved in Canada

August 28, 2012 2:55 am by | 0 Comments

COPENHAGEN (Reuters) - Danish pharmaceutical group Lundbeck said on Tuesday it had received approval from Health Canada for its cancer treatment Treanda which is used to treat two common types ... Read more
Sanofi pulls leukemia drug ahead of possible OK for Lemtrada to treat MS

Sanofi pulls leukemia drug ahead of possible OK for Lemtrada to treat MS

August 20, 2012 12:38 pm by | 0 Comments

PARIS (Reuters) - Sanofi's rare disease unit Genzyme is pulling leukaemia drug Campath to prepare for its launch under a different dosage and as a multiple sclerosis treatment that will ... Read more
Pharmacyclics Triggers Significant Milestone Payment, Provides Clinical Update

Pharmacyclics Triggers Significant Milestone Payment, Provides Clinical Update

August 1, 2012 6:38 am by | 0 Comments

Pharmacyclics, Inc. (Nasdaq: PCYC) announced today that the international Phase III randomized, multicenter, open-label clinical trial, RESONATE (PCYC-1112), of ibrutinib versus ofatumumab for patients with relapsed or refractory chronic lymphocytic... ... Read more
GSK leukemia treatment Arzerra filed for regulatory approval in Japan

GSK leukemia treatment Arzerra filed for regulatory approval in Japan

April 30, 2012 5:19 pm by | 0 Comments

Leukemia treatment Arzerra, developed by GlaxoSmithKline (NYSE:GSK) and drug partner Genmab (CSE:GEN), has been submitted for approval in Japan.Arzerra has currently received regulatory approval in the United States and Europe ... Read more
HTLV blood screening test from RTP diagnostics firm Avioq gets FDA OK

HTLV blood screening test from RTP diagnostics firm Avioq gets FDA OK

March 28, 2012 12:00 pm by | 0 Comments

The U.S. Food and Drug Administration has approved a new test for blood donations, just the second test available to screen for two viruses linked to leukemia and neurologic disorders.The ... Read more
Formula Pharmaceuticals raising $13 million for leukemia vaccine clinical trials

Formula Pharmaceuticals raising $13 million for leukemia vaccine clinical trials

December 2, 2011 6:08 pm by | 0 Comments

Formula Pharmaceuticals is raising $13 million in a series B financing round for a vaccine to be used during first remission for acute myeloid leukemia and other aggressive cancers.The investment ... Read more
Eusa Pharma gets green light for drug treatment of leukemia

Eusa Pharma gets green light for drug treatment of leukemia

November 18, 2011 1:35 pm by | 0 Comments

Eusa Pharma, a British drug development company with its North American headquarters in Langhorne, Pennsylvania, has received approval from the U.S. Food and Drug Administration for its orphan drug Erwinaze ... Read more